Rogier Rooswinkel PhD
General Partner
Developing the next generation TIL therapies for solid tumors
Achilles Therapeutics is a biopharmaceutical company developing personalized Tumor Infiltrating Lymphocyte (TIL) therapies targeting clonal neoantigens: protein markers unique to each individual that are present on the surface of all the patient’s cancer cells. CEO Iraj Ali
Human Health
UK
Achilles Therapeutics Limited
Stevenage Bioscience Catalyst,
Gunnels Wood Road,
Stevenage, Hertfordshire,
SG1 2FX
Industry
Biotech
Status
Past
Location
UK
Forbion team